Product
Supplier
Encyclopedia
Inquiry
FOXO4 buy - large image1
FOXO4 buy - image1

FOXO4

2 Inquiries

Unit Price:

$1/MT FOB

Get Latest Price
CAS No.:

271597-12-7

Grade:

Pharmaceutical Grade

Port:

SZ

Packaging:

1mg

Price valid (until):

2026-09-12

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Cagrilintide,Amycretin,BI-456906

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    FOXO4-DRI is a synthetic peptide studied for cellular senescence, FOXO4-p53 signaling, and aging research.

    Items Specifications






    ECHEMI Editorial Reference
    Myostatin is a kind of TGF-β family discovered as a factor involved in the modulation of the number of muscles. It inhibits the growth of skeletal muscles, and in knockout mice, an increase in skeletal muscles and a decrease in body fat mass have been reported. Myostatin activity is inhibited by follistatin, an activin-binding protein and myostatin propeptide. Growth Differentiation Factor 8 (GDF-8), also known as myostatin, is a member of the TGF-beta superfamily expressed specifically in developing and adult skeletal muscle. GDF-8 cDNA encodes a 376 amino acid (aa) prepropeptide with a 24 aa residue signal peptide, a 223 aa residue amino-terminal propeptide, and a 109 aa residue carboxy-terminal mature protein. Mature GDF-8 contains the canonical 7-cysteine motif common to other TGF-beta superfamily members.

    Basic Info
    Product Name:

    Myostatin(GDF-8), Human, recombinant

    Other Name:

    Myostatin(GDF-8), Human, recombinant;Myostatin (GDF-8) 1mg

    CAS No.:

    271597-12-7

    Molecular Weight:

    0

    Categories:

    Polypeptide

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Cagrilintide,Amycretin,BI-456906

    Location:

    1603-1, C Building, Wanxia Center, Houhaibin Road, Nanshan, Shenzhen, China

    Payment Terms:

    100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    201-300

    Year of Establishment:

    2025

    ">
  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Lithuania

    gdf8

    10 G Feb 28, 2026
    United States

    Gdf-8

    10 MG Feb 22, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.